Frederick A Page, Shayam Suseelan, Gayatri Kulkarni, Joseph Nowell, Paul Edison
{"title":"The heterogeneity of regional cortical atrophy in early Alzheimer’s disease","authors":"Frederick A Page, Shayam Suseelan, Gayatri Kulkarni, Joseph Nowell, Paul Edison","doi":"10.1002/alz.092522","DOIUrl":null,"url":null,"abstract":"BackgroundCortical atrophy in Alzheimer’s disease (AD) is typically thought to commence in the medial temporal lobe. However, growing evidence suggests that this may not be true for all patients. Here, we explored atrophy patterns in patients with mild cognitive impairment (MCI) and AD and whether atrophy patterns are associated with specific clinical and neuropathological outcomes.Methods1124 AD and MCI patients were selected from the Alzheimer’s Disease Neuroimaging Initiative. Baseline 3T magnetic resonance imaging scans were processed for all patients who were then subtyped based on regions of predominant atrophy. Baseline cognitive performance and rates of cognitive decline over one year were compared between atrophy subtypes. Regional tau pathology was also evaluated with [18F] AV1451 positron emission tomography.ResultsThe following atrophy subtypes were identified: medial‐temporal dominant, frontal‐dominant, parietal‐dominant, diffuse, and occipital‐dominant. Baseline cognitive performance and tau were indicated to differ between subtypes.ConclusionInitial cortical atrophy in AD and MCI may be highly heterogeneous. Additionally, since atrophy subtypes showed unique cognitive performances and tau distributions, they may respond differently to treatment. This study provides grounds for an increased research focus on cortical atrophy in regions outside the medial temporal lobe, especially the parietal lobe.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"81 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.092522","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundCortical atrophy in Alzheimer’s disease (AD) is typically thought to commence in the medial temporal lobe. However, growing evidence suggests that this may not be true for all patients. Here, we explored atrophy patterns in patients with mild cognitive impairment (MCI) and AD and whether atrophy patterns are associated with specific clinical and neuropathological outcomes.Methods1124 AD and MCI patients were selected from the Alzheimer’s Disease Neuroimaging Initiative. Baseline 3T magnetic resonance imaging scans were processed for all patients who were then subtyped based on regions of predominant atrophy. Baseline cognitive performance and rates of cognitive decline over one year were compared between atrophy subtypes. Regional tau pathology was also evaluated with [18F] AV1451 positron emission tomography.ResultsThe following atrophy subtypes were identified: medial‐temporal dominant, frontal‐dominant, parietal‐dominant, diffuse, and occipital‐dominant. Baseline cognitive performance and tau were indicated to differ between subtypes.ConclusionInitial cortical atrophy in AD and MCI may be highly heterogeneous. Additionally, since atrophy subtypes showed unique cognitive performances and tau distributions, they may respond differently to treatment. This study provides grounds for an increased research focus on cortical atrophy in regions outside the medial temporal lobe, especially the parietal lobe.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.